RELATED CONTENT
NEWS
- Pharmacyclics raises $57M to advance tyrosine kinase inhibitor for blood cancers
- 2011 US submission for Genentech/Curis' vismodegib in basal cell carcinoma
- NICE gives Roche's MabThera final nod for non-Hodgkin's lymphoma
- Allos' Folotyn extends PFS and defers resistance to other drugs in lymphoma

